ViruSure, an Asahi Kasei company and global leader in pathogen safety testing for biopharmaceuticals, today announced the launch of the world’s first GMP-validated adventitious viral agent (AVA) ...

Controlling drug-to-antibody ratio and scalable reactors are key to reliable antibody-drug conjugate manufacturing success.

Nina Bauer of FUJIFILM Cellular Dynamics shares insight on addressing challenges and supporting developers heading towards commercialization.

GelMEDIX Inc., a biotechnology company developing regenerative therapies to restore vision, and Catalent, Inc., the leader in enabling the development and supply of better treatments for patients ...

Holland & Barrett’s Global Production Centre is rapidly redefining what contract manufacturing looks like in the health and ...

Upperton has formally submitted its application to the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for approval of its 7,000 sq. ft sterile manufacturing facility. This submission ...

First-in-class solution consolidates multiple assays into a single test, enabling broader viral detection, faster time-to-result and more confident decision-making in regulated biopharmaceutical ...

SEDEMAC Mechatronics shares are set to list on NSE and BSE on March 11, with grey market trends indicating a flat to discounted listing for investors.

We’re running million-dollar production lines on ancient software because no one wants to risk a shutdown, but ignoring that "time bomb" is becoming way too risky.

(NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today announced financial results for the fourth quarter and year ended ...

From analytical control through downstream processes to manufacturing, BsAbs present challenges in protein expression, purity, and stability.